2017
The clinical utility of the Medication Adherence Questionnaire (MAQ) in an alcohol pharmacotherapy trial
Zweben A, Piepmeier M, Fucito L, O'Malley S. The clinical utility of the Medication Adherence Questionnaire (MAQ) in an alcohol pharmacotherapy trial. Journal Of Substance Use And Addiction Treatment 2017, 77: 72-78. PMID: 28476276, PMCID: PMC5480370, DOI: 10.1016/j.jsat.2017.04.001.Peer-Reviewed Original ResearchConceptsMedication Adherence QuestionnaireMedication adherenceAdherence QuestionnaireMedical managementTreatment attendanceAlcohol pharmacotherapy trialsAlcohol-dependent smokersTreatment satisfaction ratingsBrief psychosocial treatmentsAlcohol use disorderMM sessionsPharmacology treatmentBaseline characteristicsBaseline demographicsAlcohol pharmacotherapyMedication nonadherenceUnintentional nonadherenceAdherence groupPharmacotherapy trialsDependent smokersTreatment adherenceSingle administrationPatient ratingsTreatment periodClinical utility
2016
Longitudinal Findings From a Randomized Clinical Trial of Naltrexone for Young Adult Heavy Drinkers
DeMartini KS, Gueorguieva R, Leeman RF, Corbin WR, Fucito LM, Kranzler HR, O’Malley S. Longitudinal Findings From a Randomized Clinical Trial of Naltrexone for Young Adult Heavy Drinkers. Journal Of Consulting And Clinical Psychology 2016, 84: 185-190. PMID: 26654213, PMCID: PMC4941818, DOI: 10.1037/ccp0000053.Peer-Reviewed Original ResearchConceptsPercent days abstinentFirst placebo-controlled trialPercent days heavy drinkingHeavy drinkingPlacebo-controlled trialLong-term outcomesHeavy drinking daysYoung adults ages 18Adults ages 18Naltrexone conditionActive medicationPlacebo groupPharmacotherapy trialsAdult heavy drinkersYoung adult heavy drinkersNonsignificant decreaseSignificant benefitsYear posttreatmentDays abstinentDrinking daysMost outcomesSingle interventionHeavy drinkersTreatment improvementAge 18
2009
Effective Strategies for Maintaining Research Participation in Clinical Trials
Zweben A, Fucito LM, O'Malley SS. Effective Strategies for Maintaining Research Participation in Clinical Trials. Therapeutic Innovation & Regulatory Science 2009, 43: 459-467. PMID: 24311825, PMCID: PMC3848036, DOI: 10.1177/009286150904300411.Peer-Reviewed Original Research